Capital International Investors Boosts Holdings in Teleflex Incorporated $TFX

Capital International Investors grew its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 24.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 455,825 shares of the medical technology company’s stock after acquiring an additional 89,272 shares during the quarter. Capital International Investors’ holdings in Teleflex were worth $55,629,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Ruffer LLP purchased a new position in shares of Teleflex during the fourth quarter worth approximately $5,154,000. Waterfront Wealth Inc. purchased a new position in shares of Teleflex during the fourth quarter worth approximately $2,050,000. Eos Management L.P. purchased a new position in shares of Teleflex during the fourth quarter worth approximately $3,763,000. Universal Beteiligungs und Servicegesellschaft mbH raised its stake in shares of Teleflex by 227.5% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock worth $3,395,000 after acquiring an additional 19,327 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Teleflex by 41.5% during the third quarter. JPMorgan Chase & Co. now owns 123,343 shares of the medical technology company’s stock worth $15,092,000 after acquiring an additional 36,178 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Performance

Shares of TFX stock opened at $131.84 on Tuesday. The stock has a fifty day moving average of $127.50 and a 200 day moving average of $118.31. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67. The firm has a market capitalization of $5.84 billion, a price-to-earnings ratio of -5.78, a PEG ratio of 0.97 and a beta of 0.82. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. During the same quarter last year, the firm posted $1.44 earnings per share. The firm’s revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, research analysts expect that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be issued a $0.34 dividend. The ex-dividend date is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is -5.96%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on TFX. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $140.00 to $160.00 in a report on Monday. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Needham & Company LLC raised their target price on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Wells Fargo & Company raised their target price on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. Finally, Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price on the stock in a report on Monday, April 13th. Four analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $146.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.